Association found between renal cell cancinoma and long-term use of non-Aspirin anti-inflammatory drugs
Long-term use of non-Aspirin anti-inflammatory drugs ( NSAIDs ) is associated with an increased risk of renal cell cancer ( RCC ).
In the United States, kidney cancer is the seventh leading type of cancer among men and the ninth leading type of cancer among women. The most common type of kidney cancer, renal cell cancer, accounts for 85% of all cases. Analgesics are among the most commonly used groups of drugs in the United States, and some appear to have protective effects against cancer. However, some epidemiologic data, mainly from case-control studies, suggest an association between analgesic use and an increased risk of renal cell carcinoma.
Eunyoung Cho, from Harvard Medical School and Brigham and Women's Hospital, Boston, and colleagues examined the relationship between analgesic use and renal cell cancer risk.
They used data from the Nurses' Health Study and the Health Professionals Follow-up Study, both prospective cohort studies. Beginning in 1990 in the Nurses' Health Study and 1986 in the Health Professionals Follow-up Study, and every two years thereafter, use of Aspirin, other NSAIDs and Acetaminophen was determined. Follow-up was 16 years and 20 years, respectively. The researchers evaluated the baseline and duration of use of analgesics. They also assessed other risk factors for renal cell carcinoma, such as body weight, smoking, recreational physical activity and history of hypertension.
Among the 77,525 women and 49,403 men included in the study, the researchers documented 333 renal cell cancer cases. No association was found between Aspirin and Acetaminophen use and renal cell cancer risk. An association was found between regular use of non-Aspirin NSAIDs and an increased risk of renal cell cancer, with a 51% increase in the relative risk. The researchers noticed a dose-response relationship between duration of non-Aspirin NSAID use and renal cell cancer risk; there was a 19% decrease in relative risk for use less than four years, a 36% increase in relative risk for use of analgesics for four years to less than 10 years and nearly three times the relative risk for use for 10 or more years.
In these large prospective studies of women and men, the researchers found that use of non-Aspirin NSAIDs was associated with an elevated risk of renal cell cancer, especially among those who took them for a long duration.
Risks and benefits should be considered in deciding whether to use analgesics; if our findings are confirmed, an increased risk of renal cell cancer should also be considered. ( Xagena )
Source: Archives of Internal Medicine, 2011